Changes to the Code
S. 987 · Protecting Life and Integrity in Research Act of 2025 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 289g–1 Research on transplantation of fetal tissue
7 changes the bill asks for here, 7 carried out
- Carried out:
in the section heading, by striking
transplantation of fetal tissue
and insertinghuman fetal tissue obtained after a miscarriage or stillbirth
; - Carried out:
by amending subsection (a) to read as follows:
(a) Establishment of program.— The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.;
- Carried out:
in paragraph (1)(B), by inserting
if the human fetal tissue is intended for transplantation,
beforethe donation
; and - Carried out:
by striking subparagraph (A); and
- Carried out:
by redesignating subparagraphs (B) and (C) as subparagraphs (A) and (B), respectively;
- Carried out:
in subsection (c)(1)(B), by striking
pursuant to a spontaneous or induced abortion or pursuant to
and insertingafter a miscarriage or
; and - Carried out:
by amending subsection (g) to read as follows:
(g) Definitions.— In this section: (1) Human fetal tissue.— The term “human fetal tissue” means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth. (2) Miscarriage.— The term “miscarriage” means the involuntary death …
§ 289g–1(a)–(c)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 289g–1. Research on | § 289g–1. Research on [inserted: human] fetal tissue[inserted: obtained after a miscarriage or stillbirth] | |||
| (a) | (a) Establishment of program | (a) Establishment of program[inserted: .—] | ||
| [inserted: The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth.] | ||||
| (a)(1) | (1) | |||
| (a)(2) | (2) | |||
| (b) | (b) Informed consent of donor | (b) Informed consent of donor | ||
| (b)(1) | (1) In general | (1) In general | ||
| In research carried out under subsection (a), human fetal tissue may be used only if the woman providing the tissue makes a statement, made in writing and signed by the woman, declaring that— | In research carried out under subsection (a), human fetal tissue may be used only if the woman providing the tissue makes a statement, made in writing and signed by the woman, declaring that— | |||
| (b)(1)(A) | (A) | (A) | ||
| the woman donates the fetal tissue for use in research described in subsection (a); | the woman donates the fetal tissue for use in research described in subsection (a); | |||
| (b)(1)(B) | (B) | (B) | ||
| the donation is made without any restriction regarding the identity of individuals who may be the recipients of transplantations of the tissue; and | [inserted: if ]the [inserted: human fetal tissue is intended for transplantation, the ]donation is made without any restriction regarding the identity of individuals who may be the recipients of transplantations of the tissue; and | |||
| (b)(1)(C) | (C) | (C) | ||
| the woman has not been informed of the identity of any such individuals. | the woman has not been informed of the identity of any such individuals. | |||
| (b)(2) | (2) Additional statement | (2) Additional statement | ||
| In research carried out under subsection (a), human fetal tissue may be used only if the attending physician with respect to obtaining the tissue from the woman involved makes a statement, made in writing and signed by the physician, declaring that— | In research carried out under subsection (a), human fetal tissue may be used only if the attending physician with respect to obtaining the tissue from the woman involved makes a statement, made in writing and signed by the physician, declaring that— | |||
| (b)(2)(A) | (A) | |||
| (b)(2)(A)(i) | (i) | |||
| (b)(2)(A)(ii) | (ii) | |||
| (b)(2)(A)(iii) | (iii) | |||
| (b)(2)(A) | [inserted: (A)] | |||
| the tissue has been donated by the woman in accordance with paragraph (1); and | the tissue has been donated by the woman in accordance with paragraph (1); and | |||
| (b)(2)(B) | [inserted: (B)] | |||
| full disclosure has been provided to the woman with regard to— | full disclosure has been provided to the woman with regard to— | |||
| (b)(2)(B)(i) | (i) | (i) | ||
| such physician’s interest, if any, in the research to be conducted with the tissue; and | such physician’s interest, if any, in the research to be conducted with the tissue; and | |||
| (b)(2)(B)(ii) | (ii) | (ii) | ||
| any known medical risks to the woman or risks to her privacy that might be associated with the donation of the tissue and that are in addition to risks of such type that are associated with the woman’s medical care. | any known medical risks to the woman or risks to her privacy that might be associated with the donation of the tissue and that are in addition to risks of such type that are associated with the woman’s medical care. | |||
| (c) | (c) Informed consent of researcher and donee | (c) Informed consent of researcher and donee | ||
| In research carried out under subsection (a), human fetal tissue may be used only if the individual with the principal responsibility for conducting the research involved makes a statement, made in writing and signed by the individual, declaring that the individual— | In research carried out under subsection (a), human fetal tissue may be used only if the individual with the principal responsibility for conducting the research involved makes a statement, made in writing and signed by the individual, declaring that the individual— | |||
| (c)(1) | (1) | (1) | ||
| is aware that— | is aware that— | |||
| (c)(1)(A) | (A) | (A) | ||
| the tissue is human fetal tissue; | the tissue is human fetal tissue; | |||
| (c)(1)(B) | (B) | (B) | ||
| the tissue may have been obtained | the tissue may have been obtained [inserted: after] a [inserted: miscarriage] or a stillbirth; and | |||
| (c)(1)(C) | (C) | (C) | ||
| the tissue was donated for research purposes; | the tissue was donated for research purposes; | |||
| (c)(2) | (2) | (2) | ||
| has provided such information to other individuals with responsibilities regarding the research; | has provided such information to other individuals with responsibilities regarding the research; | |||
§ 289g–1(e)–(g)
(c)(3)–(e)(1) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (e)(2) | (2) Research conducted by Secretary | (2) Research conducted by Secretary | ||
| The Secretary may conduct research under subsection (a) only in accordance with applicable State and local law. | The Secretary may conduct research under subsection (a) only in accordance with applicable State and local law. | |||
| (f) | (f) Report | (f) Report | ||
| The Secretary shall annually submit to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, a report describing the activities carried out under this section during the preceding fiscal year, including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section. | The Secretary shall annually submit to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, a report describing the activities carried out under this section during the preceding fiscal year, including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section. | |||
| (g) | (g) | (g) [inserted: Definitions.—] | ||
| [inserted: In this section:] | ||||
| (g)(1) | (1) [inserted: Human fetal tissue.—] | |||
| [inserted: The term “human fetal tissue” means tissue or cells obtained from a dead unborn child pursuant to an induced abortion, a miscarriage, or a stillbirth.] | ||||
| (g)(2) | (2) [inserted: Miscarriage.—] | |||
| [inserted: The term “miscarriage” means the involuntary death of an unborn child who was carried in the womb for a period of less than 20 weeks.] | ||||
| (g)(3) | (3) [inserted: Stillbirth.—] | |||
| [inserted: The term “stillbirth” means the involuntary death of an unborn child who was carried in the womb for a period of 20 weeks or more.] | ||||
| (g)(4) | (4) [inserted: Unborn child.—] | |||
| [inserted: -The term “unborn child” has the meaning given such term in section 1841(d) of title 18, United States Code.] | ||||
| (g) | ||||
42 U.S.C. § 289g–2 Prohibitions regarding human fetal tissue
5 changes the bill asks for here, 5 carried out
- Carried out:
Paragraph (1) of section 498B(c) of the Public Health Service Act (42 U.S.C. 289g–2(c)) is amended to read as follows:
(1) solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that— (A) a human pregnancy was deliberately initiated to provide such tissue; or (B) the tissue was obtained pursuant to an induced abortion; or.
- Carried out:
by striking subsection (b);
- Carried out:
by redesignating subsections (c) through (e) as subsections (b) through (d), respectively; and
- Carried out:
in paragraph (1), by striking
(a), (b), or (c)
and inserting(a) or (b)
; and - Carried out:
in paragraph (2), by striking
or (b)(3)
.
§ 289g–2(a)–(d)
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| § 289g–2. Prohibitions regarding human fetal tissue | § 289g–2. Prohibitions regarding human fetal tissue | |||
| (a) | (a) Purchase of tissue | (a) Purchase of tissue | ||
| It shall be unlawful for any person to knowingly acquire, receive, or otherwise transfer any human fetal tissue for valuable consideration if the transfer affects interstate commerce. | It shall be unlawful for any person to knowingly acquire, receive, or otherwise transfer any human fetal tissue for valuable consideration if the transfer affects interstate commerce. | |||
| (b) | (b) | |||
| (b)(1) | (1) | |||
| (b)(2) | (2) | |||
| (b)(3) | (3) | |||
| (b) | [inserted: (b)] Solicitation or acceptance of tissue from fetuses gestated for research purposes | |||
| It shall be unlawful for any person or entity involved or engaged in interstate commerce to— | It shall be unlawful for any person or entity involved or engaged in interstate commerce to— | |||
| (b)(1) | (1) | (1) | ||
| [inserted: solicit or knowingly acquire, receive, or accept a donation (excluding any transfer for purposes of autopsy or burial) of human fetal tissue knowing that—] | ||||
| (b)(1)(A) | (A) [inserted: ] | |||
| [inserted: a human pregnancy was deliberately initiated to provide such tissue; or] | ||||
| (b)(1)(B) | (B) [inserted: ] | |||
| [inserted: the tissue was obtained pursuant to an induced abortion; or] | ||||
| (c)(1) | ||||
| (b)(2) | (2) | (2) | ||
| knowingly acquire, receive, or accept tissue or cells obtained from a human embryo or fetus that was gestated in the uterus of a nonhuman animal. | knowingly acquire, receive, or accept tissue or cells obtained from a human embryo or fetus that was gestated in the uterus of a nonhuman animal. | |||
| (c) | [inserted: (c)] Criminal penalties for violations | |||
| (c)(1) | (1) In general | (1) In general | ||
| Any person who violates subsection (a) | Any person who violates subsection (a) or ([inserted: b]) shall be fined in accordance with title 18, subject to paragraph (2), or imprisoned for not more than 10 years, or both. | |||
| (c)(2) | (2) Penalties applicable to persons receiving consideration | (2) Penalties applicable to persons receiving consideration | ||
| With respect to the imposition of a fine under paragraph (1), if the person involved violates subsection (a) | With respect to the imposition of a fine under paragraph (1), if the person involved violates subsection (a) , a fine shall be imposed in an amount not less than twice the amount of the valuable consideration received. | |||
| (d) | [inserted: (d)] Definitions | |||
| For purposes of this section: | For purposes of this section: | |||
| (d)(1) | (1) | (1) | ||
| The term “human fetal tissue” has the meaning given such term in section 289g–1(g) of this title. | The term “human fetal tissue” has the meaning given such term in section 289g–1(g) of this title. | |||
| (d)(2) | (2) | (2) | ||
| The term “interstate commerce” has the meaning given such term in section 321(b) of title 21. | The term “interstate commerce” has the meaning given such term in section 321(b) of title 21. | |||
| (d)(3) | (3) | (3) | ||
| The term “valuable consideration” does not include reasonable payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue. | The term “valuable consideration” does not include reasonable payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue. | |||